Hi Juzzy
By my reckoning, updates are overdue on the:
- AIM Program;
- Anti body program (HU91);
- MK Elisa, vis-a-vis where the CE mark is taking it;
- Japanese mass screening trials; and
- Canine trials.
I don't expect additional formal notification from Quest Diagnistics unlil the end oth the year BUT they will be presenting at conferences and pointing to near term development (including biomarkers) prior to then.
From left field there is always the possibility of new licences and patent approvals.
And current thinking on the efficacy/necessity of midkine as a biomarker and midkine antibodies as a therapeutic. Perhaps the broader issues could be discussed following the conference. Input from an market analyst (with an eye for science) would also be great.
cheers
- Forums
- ASX - By Stock
- AN1
- why are people selling?
why are people selling?, page-9
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1285002 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 340000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1285002 | 0.008 |
3 | 1953225 | 0.007 |
4 | 1006527 | 0.006 |
1 | 300000 | 0.005 |
2 | 525000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 340000 | 1 |
0.010 | 100000 | 1 |
0.011 | 100000 | 1 |
0.012 | 300000 | 2 |
0.013 | 750000 | 1 |
Last trade - 16.12pm 01/07/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online